🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12164+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12164 recruiting trials

RecruitingNCT07101237

An Exploratory Study on Developing an Integrated Approach Combining Multimodal Imaging and Multi-omics Characterization of Tumor Heterogeneity for Precision Diagnosis and Treatment Optimization in Liver Cancer.

🏥 Peking Union Medical College Hospital📍 1 site📅 Started Aug 2024View details ↗
Phase 1, PHASE2RecruitingNCT06327100

Open Label Phase 1/2 Study of Tasquinimod in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), or Post-Essential Thrombocytosis Myelofibrosis (Post-ET MF)

👨‍⚕️ Lucia Masarova, MD, M.D. Anderson Cancer Center📍 1 site📅 Started Aug 2024View details ↗
NARecruitingNCT06174038

Early Age-Related Hearing Loss Investigation (EARHLI)

👨‍⚕️ Justin S Golub, MD, Columbia University📍 1 site📅 Started Aug 2024View details ↗
RecruitingNCT06805734

Natural History With Focus on Oncological Risk Evaluation in Pediatric Patients With PTEN Pathogenic Variants

🏥 Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta📍 1 site📅 Started Aug 2024View details ↗
Enrolling by InvitationNCT06061341

TruGraf Liver Gene Expression Serial Test

👨‍⚕️ Jason Wellen, MD, Washington University School of Medicine📍 2 sites📅 Started Aug 2024View details ↗
EARLY_Phase 1RecruitingNCT06632860

A Dual-targeting Tracer TATE-RGD for the Diagnosis of SSTR- and RGD- Positive Tumors

🏥 Peking Union Medical College Hospital📍 1 site📅 Started Aug 2024View details ↗
EARLY_Phase 1RecruitingNCT06562361

A Microdose Trial Investigating Binding of [68Ga]Ga-DOTA-CYS-ATH001 in Healthy Subjects and Different Patient Groups.

👨‍⚕️ Johan Vessby, Section of Gastroenterology/Hepatology SE-751 85 Uppsala, Sweden📍 3 sites📅 Started Aug 2024View details ↗
RecruitingNCT06574919

Clinical and Functional Assessment of Patients With Inherited Non-Duchenne Myopathies in Sohag University Hospital

🏥 Sohag University📍 3 sites📅 Started Aug 2024View details ↗
Phase 3RecruitingNCT06520176

Comparison Study of EAP and CG Regimens for Mobilizing Hematopoietic Stem Cells in Multiple Myeloma Patients

👨‍⚕️ Ying Lu, The Affiliated People's Hospital of Ningbo University📍 16 sites📅 Started Aug 2024View details ↗
Phase 2RecruitingNCT06161532

Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C...

👨‍⚕️ Andrea B Apolo, M.D., National Cancer Institute (NCI)📍 1 site📅 Started Aug 2024View details ↗
Phase 2RecruitingNCT06517511

Selinexor in Combination With R-CHOP as the First-line Therapy for TP53-mutated DLBCL Patients (Smart Trial)

👨‍⚕️ QingQing Cai, MD. PhD., Sun yat-sen university cancer cente📍 2 sites📅 Started Aug 2024View details ↗
RecruitingNCT06545084

Evaluation of Periapical Healing Following Endodontic Microsurgery With Leukocyte and Platelet Rich Fibrin (L-PRF)

🏥 University of Pennsylvania📍 1 site📅 Started Aug 2024View details ↗
NARecruitingNCT06550921

Ablation of Oligometastasis Combined With Lenvatinib and PD-1 Inhibitor for Advanced Hepatocellular Carcinoma

👨‍⚕️ Feng Duan, MD, Chinese PLA General Hospital📍 1 site📅 Started Aug 2024View details ↗
NARecruitingNCT06219863

Harness-based Mobility Intervention for Infants With Down Syndrome

👨‍⚕️ Jana Iverson, PhD, Boston University📍 1 site📅 Started Jul 2024View details ↗
Phase 3RecruitingNCT06350032

Investigational Trial to Evaluate Safety and Tolerability of Treprostinil in Children Diagnosed With PAH

🏥 AOP Orphan Pharmaceuticals AG📍 5 sites📅 Started Jul 2024View details ↗
RecruitingNCT06064461

Vitaccess Real MG Registry

👨‍⚕️ Mark JW Larkin, PhD, Vitaccess Ltd📍 8 sites📅 Started Jul 2024View details ↗
RecruitingNCT06377579

OBServatory of Compassionate Use of IVOsidenib in France for Patients With Acute Myeloid Leukemia

👨‍⚕️ Pierre PETERLIN, Dr, French Innovative Leukemia Organisation📍 21 sites📅 Started Jul 2024View details ↗
RecruitingNCT06502015

Biomarkers in Autoimmune Disease of Nervous System

👨‍⚕️ Dai-shi Tian, MD, Tongji Hospital📍 1 site📅 Started Jul 2024View details ↗
Phase 3RecruitingNCT06517758

A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.

🏥 Novartis Pharmaceuticals📍 110 sites📅 Started Jul 2024View details ↗
Phase 1, PHASE2RecruitingNCT06434363

Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

👨‍⚕️ Chitra Hosing, MD, MDAnderson Cancer Center📍 2 sites📅 Started Jul 2024View details ↗
← PreviousPage 262 of 609Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →